Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Thallion Pharmaceuticals Inc V.TLN



TSXV:TLN - Post by User

Post by Everswanon Jul 30, 2009 7:23am
145 Views
Post# 16177607

Look up!

Look up!
Not much resistance up.

I think Gio is right. It is now clear that those results PII will be good. Time is now ticking on our side as the trial success is measured by overall survival.

At the end of September, it will be 12 months and GBM patients don't live up to 12 month usally.

Duke University is a major center, recognized world wide for Brain Scan.

I suspect that those scans were already favorable and potentially better than expected (showing real tumor regression - not just edema reduction or BBB crossing). That's why Duke jump on board.

Duke Scientists have no previous relationship with Thallion.





Bullboard Posts